We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > EdiGene

News List

EdiGene and Neukio enter collaboration to develop next-generation immune cell therapies ExpressPharma
February 14, 2022
EdiGene, Inc and Neukio Biotherapeutics have announced an R&D collaboration to develop next-generation immune cell therapies, Neukio Biotherapeutics informed via a statement.
Abcam acquires EdiGene’s Knock-out cell lines and Lysates Portfolio biospectrumasia
July 17, 2019
Using their proprietary high throughput cell editing platform, EdiGene developed the industry’s largest off-the shelf diploid library of over 2,800 single clonal knockout (KO) cell lines
EdiGene raises $15 M in Series B funding biospectrumasia
April 11, 2019
EdiGENE, an emerging biotechnology company developing new CRISPR based therapies for the treatment of genetic ……